Pathogenesis and Roles of Treatment Arrhythmogenic Right Ventricular Cardiomyopathy: Review

Abstract: Antiarrhythmic therapy is commonly used for suppression of arrhythmias in patients with arrhythmogenic best ventricular cardiomyopathy (ARVC) in conjunction with implantable cardioverter defibrillators (ICD) and catheter ablation. The efficacy of mix flecainide and sotalol/ metoprolol treatment for patients refractory to single representatives and/or catheter ablation has actually not been well established. The main aim of this review is to explain our experience in utilizing the addition of flecainide in combination with sotalol/ metoprolol for the treatment of arrhythmias in patients with ARVC. In conclusion, The addition of flecainide in mix with sotalol/ metoprolol may be an efficient antiarrhythmic strategy for the control of ventricular arrhythmias in patients with ARVC refractory to single agent therapy and/or catheter ablation. Keywords: Antiarrhythmic therapy, sotalol/ metoprolol treatment, ventricular. Title: Pathogenesis and Roles of Treatment Arrhythmogenic Right Ventricular Cardiomyopathy: Review Author: Sahli, Abdulaziz Ali Y, Turki Hessen Anab, Ismail Mohammed Taher Sumaily, Yahya Ali Aljefri, Zyad Ali Daghriri International Journal of Healthcare Sciences ISSN 2348-5728 (Online) Research Publish Journals

Citation